tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Revvity sees FY25 EPS exceeding upper end of prior view of $4.90-$5.00
PremiumThe FlyRevvity sees FY25 EPS exceeding upper end of prior view of $4.90-$5.00
19d ago
Revvity sees Q4 revenue of about $772M, consensus $728.1M
Premium
The Fly
Revvity sees Q4 revenue of about $772M, consensus $728.1M
19d ago
Revvity up 1% at $105 following Q4 revenue pre-announcement
Premium
The Fly
Revvity up 1% at $105 following Q4 revenue pre-announcement
19d ago
Revvity price target raised to $107 from $102 at Wells Fargo
PremiumThe FlyRevvity price target raised to $107 from $102 at Wells Fargo
2M ago
BofA shakes up ratings in Biopharma Services with seven changes
Premium
The Fly
BofA shakes up ratings in Biopharma Services with seven changes
2M ago
Revvity downgraded to Neutral from Buy at BofA
Premium
The Fly
Revvity downgraded to Neutral from Buy at BofA
2M ago
Revvity price target raised to $105 from $99 at BofA
PremiumThe FlyRevvity price target raised to $105 from $99 at BofA
3M ago
Revvity price target raised to $123 from $122 at Baird
Premium
The Fly
Revvity price target raised to $123 from $122 at Baird
3M ago
Revvity price target raised to $105 from $100 at Barclays
Premium
The Fly
Revvity price target raised to $105 from $100 at Barclays
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100